Nephron Research downgraded Icon (ICLR) to Hold from Buy.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICLR:
- ICON Probes Accounting Practices, Delays 2025 Results and Withdraws Guidance
- Icon withdraws previously issued 2025 full year financial guidance.
- Icon updates ongoing internal investigation into accounting practices
- CRO peers lower after Medpace earnings, comments on cancellations
- Icon price target raised to $183 from $172 at TD Cowen